ARYZTA AG
ARYZTA AG Fundamental Analysis
ARYZTA AG (ARZTF) shows moderate financial fundamentals with a PE ratio of 10.91, profit margin of 5.42%, and ROE of 23.28%. The company generates $2.7B in annual revenue with moderate year-over-year growth of 3.36%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ARZTF's fundamental strength across five key dimensions:
Efficiency Score
WeakARZTF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentARZTF trades at attractive valuation levels.
Growth Score
ModerateARZTF shows steady but slowing expansion.
Financial Health Score
WeakARZTF carries high financial risk with limited liquidity.
Profitability Score
ModerateARZTF maintains healthy but balanced margins.
Key Financial Metrics
Is ARZTF Expensive or Cheap?
P/E Ratio
ARZTF trades at 10.91 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ARZTF's PEG of 0.14 indicates potential undervaluation.
Price to Book
The market values ARYZTA AG at 2.25 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.67 times EBITDA. This is generally considered low.
How Well Does ARZTF Make Money?
Net Profit Margin
For every $100 in sales, ARYZTA AG keeps $5.42 as profit after all expenses.
Operating Margin
Core operations generate 8.39 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $23.28 in profit for every $100 of shareholder equity.
ROA
ARYZTA AG generates $6.34 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
ARYZTA AG produces operating cash flow of $339.96M, showing steady but balanced cash generation.
Free Cash Flow
ARYZTA AG produces free cash flow of $228.92M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $7.55 in free cash annually.
FCF Yield
ARZTF converts 11.60% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.91
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.14
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.25
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.72
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.38
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.56
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.23
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How ARZTF Stacks Against Its Sector Peers
| Metric | ARZTF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.91 | 23.25 | Better (Cheaper) |
| ROE | 23.28% | 1240.00% | Weak |
| Net Margin | 5.42% | -9728.00% (disorted) | Weak |
| Debt/Equity | 1.38 | 0.77 | Weak (High Leverage) |
| Current Ratio | 0.56 | 2.54 | Weak Liquidity |
| ROA | 6.34% | -203388.00% (disorted) | Weak |
ARZTF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews ARYZTA AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-8.06%
Industry Style: Defensive, Dividend, Low Volatility
DecliningEPS CAGR
118.54%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthFCF CAGR
760.08%
Industry Style: Defensive, Dividend, Low Volatility
High Growth